Canada Revises Tobacco and Vaping Products Act in 2018

Apr.07.2022
Canada revises tobacco and e-cigarette laws to protect youths and recognize vaping as a safer alternative to smoking.

The Tobacco and Vaping Products Act (TVPA) in Canada was revised in 2018, acknowledging that electronic cigarettes are a safer alternative to smoking. The revised act also includes measures to protect minors from harm caused by the product through label and promotional restrictions.

 

According to Darryl Tempest, the Government Relations Committee of the Canadian Vaping Association, electronic cigarettes have helped millions of smokers quit, and could help even more if not for the media's misleading statements and misunderstandings about the products. As part of the TVPA review process, lawmakers must have the opportunity to hear from a wide range of experts.

 

The public consultation period for the TVPA will come to a close on April 27th.

 

Meanwhile, the TVPA (Tobacco and Vaping Products Act) is set to undergo authorized parliamentary review, while the Canadian government has initiated public consultations by April 27th, 2022. A discussion paper from Health Canada encourages adult smokers to switch to safer alternatives. "For adult smokers, there appears to be a lack of awareness that e-cigarette products pose a lesser harm nicotine source for those who are currently smoking and have fully switched to e-cigarettes. A survey conducted in 2020 found that only 22% of smokers were aware that vaping is less harmful than smoking.

 

However, section 30.43 of the TVPA prohibits "making claims that are likely to lead people to believe that health benefits may result from the use of the product or its emissions or by comparing the health effects of using the product or its emissions with those of using tobacco products or their emissions. The purpose of this ban is to prevent the public from being deceived or misled regarding the health risks of using electronic cigarette products.

 

The "list of statements for promoting electronic cigarette products" from Canada's Department of Health.

 

CVA will urge Health Canada to address the issue and include relevant risk statements for licensed professional e-cigarette shops to use, based on the submitted documents. In 2018, Health Canada proposed a list of statements for promoting e-cigarette products, which has since been left dormant and stagnant within the bureaucratic structure of the department, compromising potential public health gains from smokers switching to e-cigarettes.

 

CVA looks forward to actively participating in the review process and advocating for enhanced measures to protect youth, as well as increasing information for smokers and promoting the benefits of switching to electronic cigarettes. We encourage all stakeholders to provide feedback," said Tempest.

 

(Source: Vaping Post)

 

The Tobacco and Vaping Products Act is now open for consultation in Canada. This development was reported by the Vaping Post on April 6, 2022.

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Product | 30ml E-Liquid, 40,000 Puffs, and Three Power Settings: OXBAR Launches New DTL Product ROVOTA
Product | 30ml E-Liquid, 40,000 Puffs, and Three Power Settings: OXBAR Launches New DTL Product ROVOTA
E-cigarette brand OXBAR has launched its new DTL e-cigarette, the OXBAR ROVOTA, on its official website. The product contains 30ml of e-liquid and is officially rated for up to approximately 40,000 puffs. It has a nicotine strength of 6mg and offers around 15 flavor options. The device is equipped with a 1400mAh battery, supports Type-C charging, features a 0.4Ω dual mesh coil, and supports three power settings of 20W, 30W, and 40W.
Mar.31 by 2FIRSTS.ai
Philippine Tobacco Control Coalition Backs Raising Legal Age for Vape and Tobacco Products to 25
Philippine Tobacco Control Coalition Backs Raising Legal Age for Vape and Tobacco Products to 25
A coalition of health and child rights advocates in the Philippines said it supports Health Secretary Teodoro Herbosa’s call to raise the legal age restriction for vape and tobacco products from 18 to 25. The group said scientific evidence shows that the brain of a young person continues to develop until the mid-20s, and that nicotine exposure during that period can cause lasting impairment in impulse control, learning, and mood regulation.
Mar.11 by 2FIRSTS.ai
Azerbaijan moves to fine and confiscate e-cigarettes across supply chain; full ban expected April 1, 2026
Azerbaijan moves to fine and confiscate e-cigarettes across supply chain; full ban expected April 1, 2026
Azerbaijan is considering administrative penalties for the use, import, export, production, wholesale and retail sale, and storage for sale of e-cigarettes, including confiscation of products. The proposed amendments were discussed at a parliamentary committee meeting. The draft sets fine ranges for individuals, officials, and legal entities, and introduces a separate fine for vaping in prohibited places and public areas.
Feb.27 by 2FIRSTS.ai
FDA Renews Exposure Modification Authorization for IQOS Devices and Three HeatSticks Products
FDA Renews Exposure Modification Authorization for IQOS Devices and Three HeatSticks Products
U.S. Food and Drug Administration renewed modified risk granted orders for five IQOS products from Philip Morris Products S.A., including two IQOS system holders and chargers and three HeatSticks products. Under the renewed orders, the products may continue to be marketed with an exposure modification claim.
Apr.20 by 2FIRSTS.ai
FDA Says It Will Not Take Enforcement Action Against Zone Nicotine Pouches Until Lawsuit Is Resolved
FDA Says It Will Not Take Enforcement Action Against Zone Nicotine Pouches Until Lawsuit Is Resolved
The U.S. Food and Drug Administration has told vape manufacturer Fontem US that it does not presently intend to take enforcement action against the company’s Zone nicotine pouches while litigation over the agency’s handling of the application remains unresolved.
Apr.07 by 2FIRSTS.ai
Study: Links between internalizing mental health symptoms and nicotine/tobacco use vary by gender identity among U.S. adolescents
Study: Links between internalizing mental health symptoms and nicotine/tobacco use vary by gender identity among U.S. adolescents
A study using 2020–2023 U.S. data from the ITC Youth Tobacco and Vaping Survey (ages 16–19) reports that both nicotine/tobacco use and internalizing mental health (IMH) symptoms vary across disaggregated gender identities, and that gender identity moderates the relationship between IMH symptoms and product use.
Feb.27 by 2FIRSTS.ai